POST LEONARD E sold 1K shares of CG ONCOLOGY, INC. on the open market
Open‑market sale worth $54.5K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/5/2026ACC: 0001193125-26-259705
+8.35K
Net shares
Net buyer
$54.5K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
10.35K acquired · 2K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1K
Price / share
$0.60
Trade value
$600.00
% of position
New position
6/4/2026
0.00→1K
Common Stock
Direct
Shares
−1K
Price / share
$54.50
Trade value
$54.50K
% of position
New position
6/4/2026
1K→0.00
Total
Net shares
+0.00
Net value
-$53.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/4/2026 | M · Option Exercise | +1K | $0.60 | $600.00 | New position | 0.00 | 1K |
| Common Stock Direct | 6/4/2026 | S · Sale | −1K | $54.50 | $54.50K | New position | 1K | 0.00 |
| Total | +0.00 | -$53.90K | ||||||
Derivative Transactions2
Director Stock Option (right to buy)
Direct
Converts to
Common Stock
1K shares
Shares
−1K
Strike price
0.6
Held after
116.08K
Exercisable
—
6/4/2026
Director Stock Option (right to buy)
Direct
Converts to
Common Stock
9.35K shares
Shares
+9.35K
Strike price
56.09
Held after
9.35K
Exercisable
—
6/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) Direct | Common Stock1K shares | 6/4/2026 | M · Option Exercise | −1K | 0.6 | — | 116.08K |
| Director Stock Option (right to buy) Direct | Common Stock9.35K shares | 6/4/2026 | A · Award | +9.35K | 56.09 | — | 9.35K |